CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹634 Cr | ₹567 Cr | ₹743 Cr | ₹622 Cr | ₹761 Cr |
What is the latest Contingent Liabilities ratio of CIPLA ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹634 Cr |
Mar2023 | ₹567 Cr |
Mar2022 | ₹743 Cr |
Mar2021 | ₹622 Cr |
Mar2020 | ₹761 Cr |
How is Contingent Liabilities of CIPLA Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹634 Cr | 11.90 | |
Mar2023 | ₹567 Cr | -23.73 | |
Mar2022 | ₹743 Cr | 19.41 | |
Mar2021 | ₹622 Cr | -18.28 | |
Mar2020 | ₹761 Cr | - |
Compare Contingent Liabilities of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹125,533.3 Cr | 0.9% | 0.1% | 14.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,910.0 Cr | 2.5% | 0.2% | 17.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,035.0 Cr | 2.1% | 3.7% | 66.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,894.0 Cr | -0.6% | 0.4% | 28.3% | Stock Analytics | |
MANKIND PHARMA | ₹105,587.0 Cr | -1.2% | 5.6% | 11.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,110.0 Cr | -0.3% | -2.2% | -0.1% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 0.9% |
0.1% |
14.6% |
SENSEX | 1% |
4.3% |
8.9% |
You may also like the below Video Courses